1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor

Protein Science

Volumn 6, Issue 10, 1997, Pages 2250-2260

  Fairbrother, Wayne J ^a   Champe, Mark A ^a   Christinger, Hans W ^a   Keyt, Bruce A ^a   Starovasnik, Melissa A ^a  

^a GENENTECH INC   (United States)

Author keywords

Chemical shift; Protein secondary structure; Resonance assignments; Triple resonance NMR spectroscopy; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LYMPHOKINE; PROTEIN TYROSINE KINASE; RECOMBINANT PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; MITOSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; BINDING SITE; CHEMISTRY; CRYSTALLIZATION; DIMERIZATION; HUMAN; METABOLISM; PH;

BINDING SITES; CRYSTALLIZATION; DIMERIZATION; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYDROGEN-ION CONCENTRATION; LYMPHOKINES; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN STRUCTURE, SECONDARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030608912     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560061020     Document Type: Article

References (64)

1. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW. 1996. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a non-human primate. Arch Ophthalmology 114:66-71.
2. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL. 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487.
3. Akke M, Carr PA, Palmer AG. 1994. Heteronuclear-correlation NMR spectroscopy with simultaneous isotope filtration, quadrature detection, and sensitivity enhancement using z rotations. J Magn Reson B 104:298-302.
4. 13C-enriched proteins. J Magn Reson 88:425-431.
5. Bax A, Ikura M, Kay LE, Torchia DA, Tschudin R. 1990b. Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins. J Magn Reson 86:304-318.
6. Bax A, Pochapsky SS. 1992. Optimized recording of heteronuclear multidimensional NMR spectra using pulsed field gradients. J Magn Reson 99:638-643.
7. 15N-labeled proteins. J Magn Reson Ser B 110:65-68.
8. Cantor CR, Schimmel PR. 1980. Biophysical chemistry. San Francisco: W.H. Freeman.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
10. Carter P, Nilsson B, Burnier JP, Burdick D, Wells JA. 1989. Engineering subtilisin BPN′ for site-specific proteolysis. Proteins Struct Funct Genet 6:240-248.
11. Christinger HW, Muller YA, Berleau LT, Keyt BA, Cunningham BC, Ferrara N, de Vos AM. 1996. Crystallization of the receptor binding domain of vascular endothelial growth factor. Proteins Struct Funct Genet 26:353-357.
12. 13C-labeled proteins. J Magn Reson 97:213-217.
13. 13C-labeled proteins. J Biomol NMR 2:203-210.
14. β and CO signal assignments and the chemical shift index: Comparison with the crystal structure. J Biomol NMR 7:335-340.
15. Daopin S, Li M, Davies DR. 1993. Crystal structure of TGF-β2 refined at 1.8 Å resolution. Proteins Struct Funct Genet 17:176-192.
16. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
17. Dvorak HF, Brown LF, Detmar M, Dvorak AM. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability. and angiogenesis. Am J Pathol 146:1029-1039.
18. Ferrara N. 1995. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127-137.
19. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
20. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
21. Graña D, Gardella T, Susskind MM. 1988. The effects of mutations in the ant promoter of phage P22 depend on context. Genetics 120:319-327.
22. Grzesiek S, Bax A. 1992a. Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR. J Am Chem Soc 114:6291-6293.
23. Grzesiek S, Bax A. 1992b. An efficient experiment for sequential backbone assignment of medium-sized isotopically enriched proteins. J Magn Reson 99:201-207.
24. Grzesiek S, Bax A. 1992c. Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein. J Magn Reson 96:432-440.
25. 2O in protein NMR. Applications to sensitivity enhancement and NOE measurements. J Am Chem Soc 115:12593-12594.
26. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. 1991. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814.
27. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. 1992. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037.
28. Kay LE, Keifer P, Saarinen T. 1992a. Pure adsorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity, J Am Chem Soc 114:10663-10665.
29. Kay LE, Wittekind M, McCoy MA, Friedrichs MS, Mueller L. 1992b. 4D NMR triple-resonance experiments for assignment of protein backbone nuclei using shared constant-time evolution periods. J Magn Reson 98:443-450.
30. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N. 1996a. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271:7788-7795.
31. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N. 1996b. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271:5638-5646.
32. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844.
33. Klagsbrun M, D'Amore PA. 1991. Regulators of angiogenesis. Annu Rev Physiol 53:217-239.
34. Laskowski RA, Mac Arthur MW, Moss DS, Thornton JM. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
35. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309.
36. Löhr F, Rüterjans H. 1995. A new triple-resonance experiment for the sequential assignment of backbone resonances in proteins. J Biomol NMR 6:189-197.
37. Marion D, Ikura M, Tschudin R, Bax A. 1989a. Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins. J Magn Reson 85:393-399.
38. 15N-labeled proteins. J Am Chem Soc 111:1515-1517.
39. 2O solution. J Magn Reson 85:608-613.
40. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
41. Muhandiram DR, Kay LE. 1994. Gradient-enhanced triple-resonance three-dimensional NMR experiments with improved sensitivity. J Magn Reson Ser B 103:203-216.
42. Muller YA, Li B, Christinger HW, Wells JA, de Vos AM, Cunningham BC. 1997. Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA 94:7192-7197.
43. 15N spectroscopy. J Magn Reson 87:488-501.
44. Oefner C, D'Arcy A, Winkler FK, Eggimann B, Hosang M. 1992. Crystal structure of human platelet-derived growth factor BB. EMBO J 11:3921-3926.
45. Park JE, Keller GA, Ferrara N. 1993. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4:1317-1326.
46. Phillips HS, Hains J, Leung DW, Ferrara N. 1990. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127:965-968.
47. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznick AJ. 1992. Vascular endothelial growth factor mRNA expression in primate ovary. Endocrinology 131:254-260.
48. Schlunegger MP, Grütter MG. 1993. Refined crystal structure of human transforming growth factor β2 at 1.95 Åresolution. J Mol Biol 231:445-458.
49. Shaka AJ, Barker PB, Freeman R. 1985. Computer-optimized decoupling scheme for wideband applications and low-level operation. J Magn Reson 64:547-552.
50. Shaka AJ, Keeler J, Frenkiel T, Freeman R. 1983. An improved sequence for broadband decoupling: WALTZ-16. J Magn Reson 52:335-338.
51. Shuker SB, Hajduk PJ, Meadows RP, Fesik SW. 1996. Discovering high-affinity ligands for proteins: SAR by NMR. Science 274:1531-1534.
52. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91:2235-2243.
53. 15N spin relaxation measurements. J Magn Reson B 102:253-264.
54. 15N NMR relaxation measurements. Biochemistry 31:4394-4406.
55. Sun PD, Davies DR. 1995. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct 24:269-291.
56. Terman BC, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P. 1992. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586.
57. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-11954.
58. 15N NMR relaxation. J Am Chem Soc 117:12562-12566.
59. 13C decoupling. J Magn Reson 98:428-435.
60. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH, 1994. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269:26988-26995.
61. 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6:135-140.
62. 13C chemical-shift data. J Biomol NMR 4:171-180.
63. Wishart DS, Sykes BD. 1994b. Chemical shifts as a tool for structure determination. Methods Enzymol 239:363-392.
64. Wüthrich K. 1986. NMR of proteins and nucleic acids. New York: John Wiley & Sons, Inc.